نتایج جستجو برای: neurotrophic tyrosine kinase receptor type 2

تعداد نتایج: 3919757  

Journal: :middle east journal of cancer 0
hind dehbi genetics and molecular pathology laboratory, medical school of casablanca, hassan ii university, casablanca, morocco yaya kassogue genetics and molecular pathology laboratory, medical school of casablanca, hassan ii university, casablanca, morocco sanaa nasserddine genetics and molecular pathology laboratory, medical school of casablanca, hassan ii university, casablanca, morocco asma quessar department of onco-hematology, ibn rochd university hospital, casablanca, morocco sellama nadifi genetics and molecular pathology laboratory, medical school of casablanca, hassan ii university, casablanca, morocco

background :according to numerous studies, fms-like tyrosine kinase 3, internal tandem duplication, and the d835 mutation are associated with a poor prognostic clinical outcome in acute myeloid leukemia patients. detection of the fms-like tyrosine kinase 3 mutation in patients who present with normal karyotype acute myeloid leukemia helps in both the understanding of the disease and the treatme...

2009
Vimal Parkash Adrian Goldman Tuomo Glumoff Kari Keinänen Joel Sussman

........................................................................................................12 1. LITERATURE REVIEW...............................................................................14 1.1 NEUROTROPHIC FACTORS ....................................................................................14 1.2 THE GDNF FAMILY OF NEUROTROPHIC FACTORS ...................................

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2000
A Nanobashvili M S Airaksinen M Kokaia J Rossi F Asztély K Olofsdotter P Mohapel M Saarma O Lindvall Z Kokaia

Seizure activity regulates gene expression for glial cell line-derived neurotrophic factor (GDNF) and neurturin (NRTN), and their receptor components, the transmembrane c-Ret tyrosine kinase and the glycosylphosphatidylinositol-anchored GDNF family receptor (GFR) alpha 1 and alpha 2 in limbic structures. We demonstrate here that epileptogenesis, as assessed in the hippocampal kindling model, is...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2011

Journal: : 2023

The interaction of the neurotrophin BDNF dipeptide mimetic, compound GSB-106, with tyrosine kinase TrkB receptor specific for fullsized was studied using surface plasmon resonance. significant decrease in binding to TrkB, which preincubated shown. obtained data indicate GSB-106 receptor.

Journal: :The Journal of biological chemistry 1999
J B Easton N M Moody X Zhu D S Middlemas

Brain-derived neurotrophic factor (BDNF) promotes neuronal survival. Gaining an understanding of how BDNF, via the tropomyosin-related kinase B (TRKB) receptor, elicits specific cellular responses is of contemporary interest. Expression of mutant TrkB in fibroblasts, where tyrosine 484 was changed to phenylalanine, abrogated Shc association with TrkB, but only attenuated and did not block BDNF-...

Journal: :iranian journal of pharmaceutical research 0
ramin shekarriz md, board certified hematologist-oncologist, assistant professor, department of hematology-oncology, cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran neda koulaeinejad pharmd, resident of clinical pharmacy, faculty of pharmacy, mazandaran university of medical sciences, sari, iran anahita nosrati md, board certified pathologist, assistant professor, department of pathology, imam khomeini hospital, mazandaran university of medical sciences, sari, iran ebrahim salehifar pharmd, board certified clinical pharmacist, associated professor, department of clinical pharmacy, pharmaceutical research center, mazandaran university of medical sciences, sari, iran

sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. it was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. it has several adverse reactions on multi organ systems including hematologic system. although the neutropenia and thrombocytopenia commonly happens as gra...

Journal: :international journal of hematology-oncology and stem cell research 0
gholamreza bahoush pediatric hematology-oncology department, ali-asghar children's hospital, iran university of medical sciences, tehran, iran mardavizh albouyeh pediatric hematology-oncology department, shohada general hospital, shahid-beheshti university of medical sciences, tehran, iran parvaneh vossough 1pediatric hematology-oncology department, ali-asghar children's hospital, iran university of medical sciences, tehran, iran

introduction: imatinib mesylate is a selective inhibitor of tk and is considered now to be the frontline therapeutic agent during the chronic phase of cml. we have evaluated the efficacy of it on children with chronic-phase of cml. patients and methods: in a clinical trial study over the past 3 years, 14 patients (8 females and 6 males, 2.5-14 years old) were admitted with a diagnosis of cml. s...

Journal: :Indian Journal of Pharmaceutical Sciences 2022

Biatractylolide is an Atractylodes macrocephala derived bisesquiterpenoid that has been found treatment of dementia in model mice. This study aims to explore the therapeutic effect on vascular dementia. Network pharmacological techniques have used elaborate involved mechanisms biatractylolide treating Based PubChem database, Swiss target prediction and human gene database GeneCards, 19 common m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید